ACLOSAFE MR is a combination tablet containing Aceclofenac 100 mg and Tizanidine 2 mg, formulated to provide effective relief from pain associated with muscle spasm, stiffness, and inflammation. This combination is commonly used in conditions where painful muscle tightness and restricted movement occur together. Aceclofenac works as an anti-inflammatory and pain-relieving agent that helps reduce swelling and discomfort, while Tizanidine acts as a muscle relaxant that helps ease muscle spasm and improve movement comfort.
ACLOSAFE MR is often considered in the management of back pain, neck pain, muscle strain, joint-related discomfort, spondylitic pain, and other musculoskeletal conditions where both inflammation and muscle spasm need attention. Its dual-action formulation supports improved mobility, reduced tenderness, and better day-to-day comfort, especially in painful conditions linked with muscle stiffness.
Manufactured with a strong emphasis on pharmaceutical quality, safety, and consistency, ACLOSAFE MR is designed to meet trusted healthcare standards. Its convenient tablet form makes it practical for use under proper medical guidance. With dependable formulation, quality packaging, and a focus on effective pain and muscle spasm management, ACLOSAFE MR serves as a reliable option for supportive musculoskeletal care and improved patient comfort.
ACLOSAFE P is a combination tablet containing Aceclofenac 100 mg and Paracetamol 325 mg, formulated to provide effective relief from pain, inflammation, and fever associated with a variety of conditions. This combination is commonly used where both anti-inflammatory action and pain management are needed together. Aceclofenac helps reduce inflammation, swelling, and joint or muscle discomfort, while Paracetamol supports pain relief and helps control fever, making the formulation useful in everyday clinical practice.
ACLOSAFE P is often considered in conditions such as body pain, joint pain, muscle strain, back pain, dental pain, post-operative discomfort, and inflammatory conditions where quick and dependable relief is important. The balanced combination works to improve comfort and support daily functioning by addressing both the cause of inflammation and the sensation of pain.
Manufactured with a strong focus on pharmaceutical quality, safety, and consistency, ACLOSAFE P is prepared to meet trusted healthcare standards. Its tablet form offers convenient administration and reliable support when used under proper medical guidance. With quality packaging and a dependable formulation, ACLOSAFE P serves as a practical option for pain and inflammation management in modern healthcare use.
ACLOSAFE SP is a combination tablet containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg, formulated to provide effective relief from pain, inflammation, swelling, and discomfort associated with various musculoskeletal and inflammatory conditions. This combination is commonly used when patients require stronger support for painful conditions where tissue inflammation and swelling are also present. Aceclofenac helps reduce inflammation and pain, Paracetamol supports additional pain relief and fever control, while Serratiopeptidase works to help reduce swelling and promote improved recovery in inflamed tissues.
ACLOSAFE SP is often considered in conditions such as joint pain, muscle pain, back pain, sports injuries, dental pain, post-operative swelling, and other inflammatory conditions where comprehensive relief is needed. Its multi-action formulation helps improve comfort, reduce tenderness, and support smoother recovery in day-to-day medical management.
Manufactured with a strong emphasis on pharmaceutical quality, safety, and consistency, ACLOSAFE SP is designed to meet trusted healthcare standards. Its convenient tablet form and dependable composition make it a practical choice when used under proper medical guidance. With reliable packaging and quality-focused formulation, ACLOSAFE SP provides trusted support for effective pain, inflammation, and swelling management.
ANXYDEP M is a combination tablet containing Flupentixol 0.5 mg and Melitracen 10 mg, formulated to support the management of anxiety, low mood, emotional stress, and related psychosomatic symptoms. This combination is commonly considered in situations where mental tension, nervousness, irritability, and mild depressive symptoms affect daily comfort and overall well-being. Flupentixol helps provide calming and mood-supportive benefits, while Melitracen contributes to emotional balance and improved mental stability.
ANXYDEP M is often used in treatment plans where patients need support for both anxiety-related discomfort and depressive symptoms under professional medical supervision. Its balanced formulation is designed to help improve mood, reduce mental stress, and support better day-to-day functioning. In some cases, it may also be considered where emotional strain is linked with sleep disturbance, fatigue, or reduced interest in routine activities.
Manufactured with a strong focus on pharmaceutical quality, safety, and consistency, ANXYDEP M is prepared to meet trusted healthcare standards. Its convenient tablet form and dependable formulation make it a practical option when prescribed appropriately. As with all such medicines, it should be used strictly under the guidance of a qualified healthcare professional to ensure suitability, correct dosage, and safe, effective use.
